Novo Nordisk Eliminating 400 Jobs in R&D Restructuring

Novo Nordisk said it will eliminate 400 R&D employees in its headquarters country of Denmark and China, in a restructuring the company said was designed to accelerate the expansion and diversification of its pipeline across serious chronic diseases.The 400 represent less than 1% of the 42,682 employees in 79 countries that Novo Nordisk said it employed at the end of last year, according to its Annual Report 2017 .Under the restructuring, Novo Nordisk said, the company’s R&D activit